沃特世（WAT）今日盘前股价大幅下跌11.88%，引起了投资者的广泛关注。
消息面上，医疗设备制造商百通迪金森（BDX.N）下调了其2026财年的利润预期，以反映将其生物科学与诊断部门分离并出售给沃特世的交易。该交易预计于今日完成，沃特世曾称此项收购对其业务具有“变革性”，将扩大公司在临床和诊断应用领域的业务范围。然而，市场可能对此次收购的整合风险、财务影响或该部门的前景存在担忧，从而引发了股价的剧烈波动。
沃特世（WAT）今日盘前股价大幅下跌11.88%，引起了投资者的广泛关注。
消息面上，医疗设备制造商百通迪金森（BDX.N）下调了其2026财年的利润预期，以反映将其生物科学与诊断部门分离并出售给沃特世的交易。该交易预计于今日完成，沃特世曾称此项收购对其业务具有“变革性”，将扩大公司在临床和诊断应用领域的业务范围。然而，市场可能对此次收购的整合风险、财务影响或该部门的前景存在担忧，从而引发了股价的剧烈波动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.